Ladenburg Thalmann Financial Services’s Fortress Biotech FBIO Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$8K	Buy	213 +146	+218%	+$3.75K	﹤0.01%	4581
2019 Q3	$1K	Hold	67	–	–	﹤0.01%	5104
2019 Q2	$2K	Hold	67	–	–	﹤0.01%	4959
2019 Q1	$2K	Hold	67	–	–	﹤0.01%	4928
2018 Q4	$1K	Hold	67	–	–	﹤0.01%	5031
2018 Q3	$2K	Hold	67	–	–	﹤0.01%	4864
2018 Q2	$5K	Hold	67	–	–	﹤0.01%	4577
2018 Q1	$5K	Hold	67	–	–	﹤0.01%	4577
2017 Q4	$4K	Hold	67	–	–	﹤0.01%	4590
2017 Q3	$4K	Buy	+67	New	+$4.52K	﹤0.01%	4467

Other funds holding FBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

LFAS

Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ladenburg Thalmann Financial Services's FBIO Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Fortress Biotech (FBIO) stake by 218% in Q4 2019, buying an estimated $3.75K and bringing the position to 213 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #4581.

Ladenburg Thalmann Financial Services first reported a position in FBIO in Q3 2017 and has held it in 10 quarters since. 54 funds tracked by Wall St. Rank hold FBIO as of Q4 2019.

Ladenburg Thalmann Financial Services held 213 shares of Fortress Biotech worth $8K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 146 Fortress Biotech shares in Q4 2019, an estimated $3.75K.
Fortress Biotech made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4581 holding.
Ladenburg Thalmann Financial Services first reported a position in Fortress Biotech in Q3 2017 and has held it in 10 quarters since.
54 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.